Economic burden of multiple sclerosis: a cross-sectional study in Iran
Abstract Background Multiple Sclerosis (MS) is a chronic debilitating disease that imposes a heavy socioeconomic burden on societies. This study aimed to determine the economic burden of MS on patients using the first (CinnoVex and ReciGen) and second (Fingolimod and Natalizumab) drug therapy lines....
Main Authors: | Mehdi Rezaee, Khosro Keshavarz, Sadegh Izadi, Abdosaleh Jafari, Ramin Ravangard |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2022-01-01
|
Series: | Health Economics Review |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13561-021-00350-y |
Similar Items
-
Economic burden of major depressive disorder: a case study in Southern Iran
by: Khosro Keshavarz, et al.
Published: (2022-08-01) -
Economic burden of breast cancer: a case of Southern Iran
by: Faride Sadat Jalali, et al.
Published: (2023-08-01) -
Economic burden estimation associated with dengue and chikungunya in Gujarat, India
by: Jaspreet Kaur, et al.
Published: (2022-01-01) -
Economic Burden of Pediatric Asthma: Annual Cost of Disease in Iran
by: Laleh SHARIFI, et al.
Published: (2018-02-01) -
A Study on the Direct and Indirect Costs of Multiple Sclerosis Based on Expanded Disability Status Scale Score in Khuzestan, Iran
by: Amin Torabipour, et al.
Published: (2014-01-01)